Filing metadata

Accession number
0000950170-24-141162
Form type
Form 4
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Dec 30, 2024
Reporting period
Dec 26, 2024
Description
Insider transaction

Explore SEC Filings Hub